CRACR2A and myalgic encephalomeyelitis/chronic fatigue syndrome: Only three snps of 50 remained, on genes EFCAB4B, LINC01171, and MORN2, that could be shown to meet the original criterion of at least double in CFS patients compared to a comparable 23andMe control, all hovering at a ratio of about 2.0.